Stephens Consulting’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.54K Hold
215
﹤0.01% 336
2025
Q3
$3.41K Hold
215
﹤0.01% 295
2025
Q2
$2.46K Hold
215
﹤0.01% 478
2025
Q1
$2.91K Hold
215
﹤0.01% 415
2024
Q4
$3.63K Hold
215
﹤0.01% 430
2024
Q3
$4.37K Hold
215
﹤0.01% 407
2024
Q2
$4.85K Hold
215
﹤0.01% 409
2024
Q1
$5.65K Hold
215
﹤0.01% 354
2023
Q4
$6.78K Hold
215
﹤0.01% 350
2023
Q3
$6.03K Hold
215
﹤0.01% 359
2023
Q2
$7.93K Hold
215
﹤0.01% 336
2023
Q1
$6.44K Hold
215
﹤0.01% 371
2022
Q4
$6.58K Hold
215
﹤0.01% 351
2022
Q3
$5.3K Hold
215
﹤0.01% 402
2022
Q2
$6.88K Hold
215
0.01% 377
2022
Q1
$6.77K Hold
215
0.01% 401
2021
Q4
$7.21K Buy
+215
New +$6.7K 0.01% 436

Other funds holding CC

Stephens Consulting's CC Position: Q4 2025 in Review

Stephens Consulting held its Chemours (CC) position steady in Q4 2025 at 215 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #336.

Stephens Consulting first reported a position in CC in Q4 2021 and has held it in 17 quarters since. The position peaked at $7.93K in Q2 2023. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

  • Stephens Consulting held 215 shares of Chemours worth $2.54K as of Q4 2025.
  • Stephens Consulting left its Chemours share count unchanged in Q4 2025.
  • Chemours made up ﹤0.01% of Stephens Consulting's portfolio in Q4 2025, its #336 holding.
  • Stephens Consulting first reported a position in Chemours in Q4 2021 and has held it in 17 quarters since.
  • Stephens Consulting's Chemours position peaked at $7.93K in Q2 2023.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.